Charts APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. 2026-09-10			5-day change	1st Jan Change
1,854.00 ^KRW	-2.37%		+2.66%	-62.92%

Sep. 03	Aprogen Medicines Inc. announced that it expects to receive KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI
Aug. 13	APTOCROM Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Korea S.E.KRW

Markets		Quality
Korea S.E.	A109960	End-of-day quote

ProRealTime Chart